Search

Jean F. Voltaire

Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )

Most Active Art Unit
2466
Art Unit(s)
2466, 2417
Total Applications
487
Issued Applications
381
Pending Applications
55
Abandoned Applications
68

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5835436 [patent_doc_number] => 20060247267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'SNS-595 and methods of using the same' [patent_app_type] => utility [patent_app_number] => 11/478765 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4003 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247267.pdf [firstpage_image] =>[orig_patent_app_number] => 11478765 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/478765
Pharmaceutical compositions of (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid Jun 28, 2006 Issued
Array ( [id] => 4995180 [patent_doc_number] => 20070010525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Method and compositions for modulating neuropeptide hormone secretion' [patent_app_type] => utility [patent_app_number] => 11/475010 [patent_app_country] => US [patent_app_date] => 2006-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7554 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010525.pdf [firstpage_image] =>[orig_patent_app_number] => 11475010 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/475010
Method and compositions for modulating neuropeptide hormone secretion Jun 26, 2006 Abandoned
Array ( [id] => 4995182 [patent_doc_number] => 20070010527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => '4-Anilino-3-quinolinecarbonitriles for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/473540 [patent_app_country] => US [patent_app_date] => 2006-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5522 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010527.pdf [firstpage_image] =>[orig_patent_app_number] => 11473540 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/473540
4-Anilino-3-quinolinecarbonitriles for the treatment of cancer Jun 21, 2006 Abandoned
Array ( [id] => 4760026 [patent_doc_number] => 20080312252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Combination of Organic Compounds' [patent_app_type] => utility [patent_app_number] => 11/915650 [patent_app_country] => US [patent_app_date] => 2006-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6394 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312252.pdf [firstpage_image] =>[orig_patent_app_number] => 11915650 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/915650
Combination of pyrimidylaminobenzamide compounds and imatinib for treating gastrointestinal stromal tumours Jun 1, 2006 Issued
Array ( [id] => 4813965 [patent_doc_number] => 20080194596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Therapeutic Combination Including a Selective Erbb2 Inhibitor' [patent_app_type] => utility [patent_app_number] => 11/914924 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27847 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194596.pdf [firstpage_image] =>[orig_patent_app_number] => 11914924 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/914924
Therapeutic Combination Including a Selective Erbb2 Inhibitor May 21, 2006 Abandoned
Array ( [id] => 7712561 [patent_doc_number] => 08093295 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Formulations of suberoylanilide hydroxamic acid and methods for producing the same' [patent_app_type] => utility [patent_app_number] => 11/663165 [patent_app_country] => US [patent_app_date] => 2006-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26524 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093295.pdf [firstpage_image] =>[orig_patent_app_number] => 11663165 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/663165
Formulations of suberoylanilide hydroxamic acid and methods for producing the same May 15, 2006 Issued
Array ( [id] => 5015729 [patent_doc_number] => 20070258937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Deodorizing device' [patent_app_type] => utility [patent_app_number] => 11/418334 [patent_app_country] => US [patent_app_date] => 2006-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4687 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20070258937.pdf [firstpage_image] =>[orig_patent_app_number] => 11418334 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/418334
Deodorizing device May 3, 2006 Abandoned
Array ( [id] => 5149506 [patent_doc_number] => 20070049566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Methods and Compositions for inhibition of angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/411230 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9260 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049566.pdf [firstpage_image] =>[orig_patent_app_number] => 11411230 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/411230
Methods and compositions for inhibition of angiogenesis Apr 25, 2006 Issued
Array ( [id] => 5643351 [patent_doc_number] => 20060281806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Treatment and inhibition of disease conditions using flexible heteroarotinoids' [patent_app_type] => utility [patent_app_number] => 11/404689 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 17447 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281806.pdf [firstpage_image] =>[orig_patent_app_number] => 11404689 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/404689
Treatment and inhibition of disease conditions using flexible heteroarotinoids Apr 13, 2006 Abandoned
Array ( [id] => 4728109 [patent_doc_number] => 20080207653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Compositions and Method for Increasing the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/910660 [patent_app_country] => US [patent_app_date] => 2006-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3546 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207653.pdf [firstpage_image] =>[orig_patent_app_number] => 11910660 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/910660
Compositions and Method for Increasing the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Apr 6, 2006 Abandoned
Array ( [id] => 5860042 [patent_doc_number] => 20060229360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Nontoxic potentiation/sensitization of cancer therapy by supplementary treatment with combined Vitamins C and K3' [patent_app_type] => utility [patent_app_number] => 11/394311 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5744 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229360.pdf [firstpage_image] =>[orig_patent_app_number] => 11394311 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/394311
Nontoxic potentiation/sensitization of cancer therapy by supplementary treatment with combined Vitamins C and K3 Mar 29, 2006 Abandoned
Array ( [id] => 5875324 [patent_doc_number] => 20060167006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Method of treatment' [patent_app_type] => utility [patent_app_number] => 11/386141 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4253 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167006.pdf [firstpage_image] =>[orig_patent_app_number] => 11386141 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/386141
Method of treatment Mar 21, 2006 Abandoned
Array ( [id] => 4740612 [patent_doc_number] => 20080234265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Histone Deacetylase Inhibitors Sensitize Cancer Cells to Epidermal Growth Factor Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/908388 [patent_app_country] => US [patent_app_date] => 2006-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17016 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234265.pdf [firstpage_image] =>[orig_patent_app_number] => 11908388 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908388
Histone Deacetylase Inhibitors Sensitize Cancer Cells to Epidermal Growth Factor Inhibitors Mar 12, 2006 Abandoned
Array ( [id] => 6588778 [patent_doc_number] => 20100061994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'MEDICAL USES OF 39-DESMETHOXYRAPAMYCIN AND ANALOGUES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/908367 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23174 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061994.pdf [firstpage_image] =>[orig_patent_app_number] => 11908367 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908367
MEDICAL USES OF 39-DESMETHOXYRAPAMYCIN AND ANALOGUES THEREOF Mar 9, 2006 Abandoned
Array ( [id] => 10547363 [patent_doc_number] => 09271963 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Selective inhibitors of human corticosteroid synthases' [patent_app_type] => utility [patent_app_number] => 11/885605 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 25240 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11885605 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/885605
Selective inhibitors of human corticosteroid synthases Mar 1, 2006 Issued
Array ( [id] => 5625996 [patent_doc_number] => 20060264501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Acid containing oxaliplatin formulations' [patent_app_type] => utility [patent_app_number] => 11/363542 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10745 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264501.pdf [firstpage_image] =>[orig_patent_app_number] => 11363542 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/363542
Acid containing oxaliplatin formulations Feb 27, 2006 Abandoned
Array ( [id] => 4728114 [patent_doc_number] => 20080207658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Pharmaceutical Combination of Bcr-Abl and Raf Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/909013 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7725 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207658.pdf [firstpage_image] =>[orig_patent_app_number] => 11909013 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/909013
Pharmaceutical Combination of Bcr-Abl and Raf Inhibitors Feb 23, 2006 Abandoned
11/362566 Pharmaceutical compositions Feb 23, 2006 Abandoned
Array ( [id] => 123148 [patent_doc_number] => 07705010 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Use of minoxidil sulfate as an anti-tumor drug' [patent_app_type] => utility [patent_app_number] => 11/813461 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5766 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705010.pdf [firstpage_image] =>[orig_patent_app_number] => 11813461 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/813461
Use of minoxidil sulfate as an anti-tumor drug Feb 21, 2006 Issued
Array ( [id] => 5656499 [patent_doc_number] => 20060142235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Method of reducing and treating UVB-induced immunosuppression' [patent_app_type] => utility [patent_app_number] => 11/358017 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2538 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142235.pdf [firstpage_image] =>[orig_patent_app_number] => 11358017 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/358017
Method of reducing and treating UVB-induced immunosuppression Feb 20, 2006 Abandoned
Menu